The EORTC QLU-C10D distinguished better between cancer patients and the general population than PROPr and EQ-5D-5L in a cross-sectional study

Autor: Döhmen, Annika, Obbarius, Alexander, Kock, Milan, Nolte, Sandra, Sidey-Gibbons, Christopher J., Valderas, José M., Rohde, Jens, Rieger, Kathrin, Fischer, Felix, Keilholz, Ulrich, Rose, Matthias, Klapproth, Christoph Paul

Publikováno v: In Journal of Clinical Epidemiology January 2025 177

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The EORTC QLU-C10D distinguished better between cancer patients and the general population than PROPr and EQ-5D-5L in a cross-sectional study.

Autor: Döhmen A; Center for Internal Medicine and Dermatology, Department of Psychosomatic Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany. Electronic address: annika.doehmen@charite.de., Obbarius A; Center for Internal Medicine and Dermatology, Department of Psychosomatic Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany; BIH Charité Digital Clinician Scientist Program, BIH Biomedical Innovation Academy, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1 10117, Berlin, Germany; Dornsife Center for Self-Report Science, University of Southern California, Los Angeles, CA, USA., Kock M; Center for Internal Medicine and Dermatology, Department of Psychosomatic Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany., Nolte S; Faculty of Medicine, Nursing and Health Sciences, Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia; School of Health Sciences, Swinburne University of Technology, Melbourne, Victoria, Australia., Sidey-Gibbons CJ; MD Anderson Center for INSPiRED Cancer Care (Integrated Systems for Patient-Reported Data), The University of Texas, MD Anderson Cancer Center, Houston, TX, USA; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Valderas JM; Division of Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Centre for Research in Health Systems Performance, National University of Singapore, Singapore, Singapore., Rohde J; Center for Internal Medicine and Dermatology, Department of Psychosomatic Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany., Rieger K; Department of Hematology, Oncology and Cancer Immunity, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany., Fischer F; Center for Internal Medicine and Dermatology, Department of Psychosomatic Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany., Keilholz U; Charité Comprehensive Cancer Center (CCCC), Department of Oncology, Charité - Universitätsmedizin Berlin, Germany., Rose M; Center for Internal Medicine and Dermatology, Department of Psychosomatic Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany., Klapproth CP; Center for Internal Medicine and Dermatology, Department of Psychosomatic Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany; BIH Charité Digital Clinician Scientist Program, BIH Biomedical Innovation Academy, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1 10117, Berlin, Germany.

Publikováno v: Journal of clinical epidemiology [J Clin Epidemiol] 2024 Nov 07; Vol. 177, pp. 111592. Date of Electronic Publication: 2024 Nov 07.